Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study

This publication has 21 references indexed in Scilit:

• Taxanes: Microtubule and Centrosome Targets, and Cell Cycle Dependent Mechanisms of Action
  Current Cancer Drug Targets, 2003
• Psoriasis
  The Lancet, 2003
• Paclitaxel Encapsulated in Cationic Liposomes Diminishes Tumor Angiogenesis and Melanoma Growth in a “Humanized” SCID Mouse Model
  Journal of Investigative Dermatology, 2003
• Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques
  The Journal of Thoracic and Cardiovascular Surgery, 2002
• The immunologic basis for the treatment of psoriasis with new biologic agents
  Journal of the American Academy of Dermatology, 2002
• THE ANTINEOPLASTIC DRUG PACLITAXEL HAS IMMUNOSUPPRESSIVE PROPERTIES THAT CAN EFFECTIVELY PROMOTE ALLOGRAFT SURVIVAL IN A RAT HEART TRANSPLANT MODEL1
  Transplantation, 2002
• Paclitaxel hypersensitivity reactions related to bee-sting allergy
  The Lancet, 2000
• Inhibition of activator protein 1 activity by paclitaxel suppresses interleukin-1-induced collagenase and stromelysin expression by bovine chondrocytes
  Arthritis & Rheumatism, 1998
• Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.
  The Journal of Experimental Medicine, 1994
• Regulation of polymorphonuclear leukocyte membrane fluidity: effect of cytoskeletal modification
  Journal of Leukocyte Biology, 1994